ATUL SARAN

Insider Reports History

Location
Monrovia, CA
Signature
/s/ Jennifer Lynn Fox, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ATUL SARAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. EVP, Chief Strat & Dev Officer Common Stock 86,645 $157,694 $1.82 28 Feb 2023 Direct

Insider Reports Filed by ATUL SARAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EBS Emergent BioSolutions Inc. 28 Feb 2023 1 -$12,021 4 EVP, Chief Strat & Dev Officer 02 Mar 2023, 13:43
EBS Emergent BioSolutions Inc. 23 Feb 2023 2 -$16,804 4 EVP, Chief Strat & Dev Officer 27 Feb 2023, 19:23
EBS Emergent BioSolutions Inc. 08 Feb 2023 2 -$27,176 4 EVP, Chief Strat & Dev Officer 10 Feb 2023, 19:35
EBS Emergent BioSolutions Inc. 28 Feb 2022 4 +$1,569,631 4 EVP, Chief Strat & Dev Officer 02 Mar 2022, 17:45
EBS Emergent BioSolutions Inc. 23 Feb 2022 2 -$55,062 4 EVP, Corp Dev, GC & Secretary 25 Feb 2022, 16:19
EBS Emergent BioSolutions Inc. 22 Feb 2022 2 -$88,007 4 EVP, Corp Dev, GC & Secretary 24 Feb 2022, 17:51